L300M in new investments for Genomics England
U.K. Prime Minister David Cameron announced over L300 million ($509.4 million) in new investments for Genomics England Ltd. (London, U.K.), which is sequencing and analyzing the genomes of 100,000 NHS patients by 2017. The investments include about L162 million ($275.1 million) from Illumina Inc. (NASDAQ:ILMN), the partner for the sequencing element of the project. In turn, Genomics England will pay Illumina about L78 million ($132.4 million) for its services.
Other new investments include L27 million ($45.8 million) from the Wellcome Trust for a sequencing hub at its genome campus in Cambridge; L24 million ($40.7 million) from the Medical Research Council for data analysis and interpretation; and up to L20 million ($34 million) from NHS for the establishment of patient sequencing centers. ...